drugset / Trial / NCT02961855

Efficacy and Safety of CLIFE1 Gel in Benign Anorectal Surgery

NCT02961855

Phase 4 Completed 120 enrolled Hospital de Viladecans
RandomizedParallel-groupTriple-blindTreatment

Summary

Double-blinded multicenter randomized clinical trial to evaluate the efficacy and safety of CLIFE2 (lidocaine, referred as treatment A) respect CLIFE1 (lidocaine plus diclofenac, referred as treatment B) in benign anorectal surgery.

Timeline

Start
2011-01
Primary completion
2013-01
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 0.5 % Topical
Comparator Lidocaine Other / unclassified 2 % Topical

Indications